Bortero 2mg Injection is a prescription medication used in the treatment of certain types of blood cancers, including multiple myeloma and mantle cell lymphoma. It belongs to the class of drugs known as proteasome inhibitors, which work by blocking the activity of proteasomes in cancer cells. Proteasomes are cellular complexes that help break down proteins, and by inhibiting them, bortezomib disrupts the growth and survival of cancer cells.

This injectable anti-cancer therapy is typically administered under the supervision of a qualified healthcare professional, often in a hospital or clinic setting. Bortezomib may be used alone or in combination with other medications such as dexamethasone or chemotherapy agents, depending on the specific treatment plan.

Bortezomib has been clinically shown to slow disease progression, reduce tumor burden, and improve survival outcomes in patients with multiple myeloma and certain lymphomas. Its mechanism selectively targets cancer cells while minimizing damage to healthy cells, making it a cornerstone in modern oncology treatment plans.